ProCE Banner Activity

COVID-19: Which Drug, When, and Why? Anti-inflammatory Agents and Immunomodulators

Podcast Episodes
In which patients with COVID-19 should we use anti-inflammatory agents and immunomodulators? Hear expert insights on the timing and role of convalescent plasma, corticosteroids, IL-6 inhibitors, and JAK inhibitors in the treatment of COVID-19.

Released: April 07, 2022

Expiration: April 06, 2023

No longer available for credit.

Share

Faculty

Vikramjit Mukherjee

Vikramjit Mukherjee, MD

Assistant Professor of Medicine
Division of Pulmonary, Critical Care, & Sleep Medicine
New York University School of Medicine
Director, Medical Intensive Care Unit
Bellevue Hospital
New York, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

This program is supported by an educational grant from

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Vikramjit Mukherjee, MD

Assistant Professor of Medicine
Division of Pulmonary, Critical Care, & Sleep Medicine
New York University School of Medicine
Director, Medical Intensive Care Unit
Bellevue Hospital
New York, New York

Vikramjit Mukherjee, MD, has no relevant conflicts of interest to report.